Oct 29, 2026 earnings call — MSR sale and leadership changes
PennyMac announced a $29 billion UPB MSR sale with net proceeds of approximately $490 million to pay down debt.
Revenue $0.5B (est $0.5B) · EPS $1.05 (est $1.27)
Key quotes
"Second, effective January 1, 2027, Kevin Ryan, currently our Chief Strategy Officer, will assume the role of Chief Financial Officer."
"Across our production workflows, process automation has progressed meaningfully with 37% live in production and the remaining 28% currently in development expected to be completed by year-end."
"And after quarter-end, we entered into an agreement to sell $29 billion in UPB of low-coupon MSRs with an expected close in the fourth quarter."
Analyst Q&A 7
mortgage servicing sale and leverage
Q (Douglas Harter · BTIG): He asked about the MSR sale details, the target level for leverage, and whether the company will retain subservicing on the sale.
A: They will use the majority of the MSR sale proceeds to pay down outstanding MSR debt. Non-funding leverage target is about 1.5x and they expect to move toward that over time. They are not retaining subservicing on this particular sale and may consider future opportunistic MSR sales.
"In terms of the MSR sale, as we mentioned, we're expecting to utilize the majority of the proceeds to pay down our outstanding MSR or some of our outstanding MSR debt." — Daniel Perotti (CFO)
consumer direct mix and broker margins
Q (Trevor Cranston · Citizens JMP): He asked how much of consumer direct 3Q volume was second lien and where consumer direct volume might stabilize, and also asked about early 4Q margin pressure in broker direct.
A: Q3 consumer direct fundings were about $3.3 billion, with roughly $700 million of closed-end seconds. They said the consumer direct focus is on cash-out and closed-end seconds and they recently launched HELOC. On broker direct, they see competitive pressure from GSE cash window and smaller originators, but they will stay disciplined and pick spots rather than chase unsustainable pricing.
"The fundings in Q3 in consumer direct were approximately $3.3 billion, of which approximately $700 million of it was closed-end seconds." — David Spector (CEO·CHAIR)
guidance and 2027 outlook
Q (Bose George · KBW): He asked to confirm the 5% expectation for 4Q and how results might trend in 2027 if the market stays flat.
A: They said the origination market is challenging and they are rightsizing production to maintain profitability. Management expects to be at low double digits by Q4 '27 at current market levels, driven by lower amortization, NII increases, Cenlar, OpEx reductions, and production changes including tech and AI deployments.
"And so as I think about the bridge from Q4 '26 to Q4 '27, I'm expecting us to be at low double digits by Q4 '27." — David Spector (CEO·CHAIR)
scale versus larger competitors
Q (Donald Fandetti · Wells Fargo): He asked whether the company has the right scale or needs more dramatic strategic alternatives to compete with larger players.
A: They said they feel very good about the company's position and track record and that they are positioned to handle demand when rates decline without rushing to add people or infrastructure. They noted strong scale on both production and servicing, recap numbers above 40%, ongoing efficiency gains, and Kevin added they will be over $1 trillion in servicing after Cenlar.
"We're really positioned really well to take advantage of any decrease in rates that come about on the production side." — David Spector (CEO·CHAIR)
capacity if rates rally; bank charter plan
Q (Crispin Love · Piper Sandler): He asked if significant capacity would be needed if rates rally and asked about plans for the Cenlar bank charter after the deal closes.
A: They said tech reduces the need to add many people; a 100 basis point rally would require fewer than 100 additional people in consumer direct. For the Cenlar bank charter, their plan is to close the deal in Q1 and work with Cenlar management to dispose of the deposits so the bank charter will be relinquished before close.
"It's less than 100 people across the consumer direct channel when historically, that number would have been multiples." — David Spector (CEO·CHAIR)
Cenlar approvals and leverage plans
Q (Ryan Shelley · BofA): He asked which approvals remain for Cenlar and whether timing could slip, and asked about aiming for 1.5x leverage and future MSR sales.
A: They said they have basically all approvals except one state and are working with the OCC to transfer deposits, so they feel comfortable with Q1 timing. On leverage, they view MSR sales as opportunistic; they have levers to pull, liquidity, and scale, and they continue to evaluate potential MSR sales but have nothing firm in the pipeline.
"We have basically all approvals, except for one state." — Kevin Ryan (CFO)
liquidity level and MSR sale accounting
Q (Gengxuan Qiu · Barclays): She asked whether the $3.5 billion liquidity level is a minimal level and whether they worry about industry liquidity risks, and whether to expect a gain on MSR sales in 4Q.
A: They said their liquidity planning and scenario analysis is robust and that, even in stress scenarios, they still have excess liquidity and can expand facilities using MSR collateral if needed. They do not expect to book a specific gain on the MSR sale; the sale was consistent with their mark and results will appear as normal fair value changes in Q4.
"As we're looking at the sizing of our facilities and our available liquidity, even in those scenarios, we still have excess liquidity for the combination of those 2 types of shocks." — Daniel Perotti (CFO)